$Evaluating the antifracture efficacy of bisphosphonates.$

Evaluating the antifracture efficacy of bisphosphonates.

Oral bisphosphonate dosing schedules have evolved from the original daily regimens to weekly (alendronate and risedronate) and monthly (risedronate and ibandronate) regimens. Intravenous (i.v.) bisphosphonates are administered less frequently-quarterly ibandronate injection and yearly zoledronic aci...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Pazianas, M, Epstein, S, Zaidi, M
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2009

Gelijkaardige items

Antifracture agents for prostate cancer patients on androgen deprivation therapy
door: Bhupendra P Singh, et al.
Gepubliceerd in: (2010-01-01)

The sequential antifracturative treatment: a meta-analysis of randomized clinical trials
door: Angelo Fassio, et al.
Gepubliceerd in: (2024-04-01)

Safety of bisphosphonates.
door: Pazianas, M, et al.
Gepubliceerd in: (2011)

Bisphosphonates and bone quality.
door: Pazianas, M, et al.
Gepubliceerd in: (2014)

Atrial fibrillation and bisphosphonate therapy.
door: Pazianas, M, et al.
Gepubliceerd in: (2010)

Potential therapeutic effects of oral bisphosphonates on the intestine.
door: Pazianas, M, et al.
Gepubliceerd in: (2011)

Safety issues with bisphosphonate therapy for osteoporosis.
door: Suresh, E, et al.
Gepubliceerd in: (2014)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
door: Pazianas, M
Gepubliceerd in: (2013)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
door: Alexander J Rodríguez, et al.
Gepubliceerd in: (2022-06-01)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
door: Alexander J Rodríguez, et al.
Gepubliceerd in: (2021-07-01)

Bisphosphonates and colon cancer: reply.
door: Pazianas, M, et al.
Gepubliceerd in: (2013)

Bisphosphonates and colon cancer: Reply
door: Pazianas, M, et al.
Gepubliceerd in: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
door: Pazianas, M, et al.
Gepubliceerd in: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
door: Pazianas M, et al.
Gepubliceerd in: (2013-10-01)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
door: Michael Pazianas
Gepubliceerd in: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates.
door: Pazianas, M, et al.
Gepubliceerd in: (2011)

Atrial fibrillation and the use of oral bisphosphonates
door: Michael Pazianas, et al.
Gepubliceerd in: (2011-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
door: Pazianas, M, et al.
Gepubliceerd in: (2010)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
door: Abrahamsen, B, et al.
Gepubliceerd in: (2013)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
door: Pazianas, M, et al.
Gepubliceerd in: (2010)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
door: Pazianas, M, et al.
Gepubliceerd in: (2014)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
door: Pazianas, M, et al.
Gepubliceerd in: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
door: Pazianas, M, et al.
Gepubliceerd in: (2008)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
door: Pazianas, M, et al.
Gepubliceerd in: (2007)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
door: Garriga, C, et al.
Gepubliceerd in: (2018)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
door: Pazianas, M, et al.
Gepubliceerd in: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
door: Pazianas, M, et al.
Gepubliceerd in: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
door: Garriga, C, et al.
Gepubliceerd in: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
door: Garriga, C, et al.
Gepubliceerd in: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
door: Garriga, C, et al.
Gepubliceerd in: (2017)

Bisphosphonates
door: Bishop, N, et al.
Gepubliceerd in: (2013)

Bisphosphonates
door: Fırat Öztürk
Gepubliceerd in: (2009-04-01)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
door: Russell, R, et al.
Gepubliceerd in: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
door: Russell, R, et al.
Gepubliceerd in: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
door: Sujata Sharma, et al.
Gepubliceerd in: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
door: İlke Coşkun Benlidayı, et al.
Gepubliceerd in: (2015-08-01)

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
door: Russell, R, et al.
Gepubliceerd in: (2008)

Bisphosphonates: An update
door: Nalliappan Ganapathy, et al.
Gepubliceerd in: (2012-01-01)

Bisphosphonates 2006
door: Russell, R
Gepubliceerd in: (2006)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
door: Pazianas, M, et al.
Gepubliceerd in: (2012)